Extracellular vesicles as mediators of injury in inhaled exposures to toxic chemicals.

细胞外囊泡作为吸入有毒化学物质造成损伤的介质。

基本信息

  • 批准号:
    10887268
  • 负责人:
  • 金额:
    $ 44.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-17 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary Sulfur mustard (SM) and chlorine have reemerged as a potential threat to both military and civilian populations. Inhaled exposures to sulfur mustard (SM) and chlorine cause acute lung injury, which can lead to respiratory failure, multiorgan dysfunction and death. Mechanisms by which pulmonary toxicity contributes to systemic injury are not clear. Our studies with inhaled halogens (chlorine and bromine) have demonstrated serious cardiac and neuronal injury. We have previously identified circulating adducts of halogens that form in the pulmonary bed and contribute towards distant organ damage and disease pathogenicity. In our inhaled SM models of injury, we demonstrated that circulating factors such as nucleic acids released from pulmonary tissues and cells can contribute significantly to lung damage and that scavenging the nucleic acids can alleviate injury and rescue from mortality. Therefore, circulating factors are critical to pulmonary and systemic injuries. Growing evidence suggests that several such factors are carried as cargo in exosomes a type of extracellular vesicles (EV). Studies have shown that EV/exosomes could be pathogenic. Our preliminary data shows that the composition of cargoes from the bronchoalveolar lavage fluid (BALF) of chlorine exposed rats are distinct from the exosomal cargo obtained from the BALF of control animals. Further, we demonstrate that exosomes isolated from the BALF of animals exposed to CEES (2-chloroethyl ethylsulfide, aka: half mustard), an analog of SM, when added to cells in culture dose-dependently increased inflammatory cytokines and procoagulation genes, important components in the pathogenesis of SM-induced and CEES-induced injuries. In our in vivo studies the SM BALF exosome content correlated with the BALF protein, a marker of leaky alveolar barrier. These studies led us to hypothesize that toxic chemical exposures result in the release of pathogenic exosomes that causes activation of the inflammatory and coagulation pathways and that blocking their biogenesis or uptake can mitigate injury and protect from acute morbidity and mortality. Accordingly, we will (a) characterize EV/exosomes derived from the BALF and plasma of rats exposed to Cl2 and CEES, (b) identify mechanisms by which EV/exosomes from these toxic chemical-exposed animals cause injury, and (c) evaluate pathogenicity of EV/exosomes derived from toxic chemical-exposed animals are test efficacy or biogenesis or uptake inhibitors. These studies will delineate mechanisms by which EV/exosomes influence pulmonary injury/disease severity and resolution and also determine whether exosomes can serve as potential therapeutic targets in mitigating organ injury caused by inhaled toxic chemicals.
项目摘要 芥子气和氯再次成为对军事和平民的潜在威胁。 吸入硫芥(SM)和氯可引起急性肺损伤,可导致呼吸道疾病。 衰竭、多器官功能障碍和死亡。肺毒性导致全身损伤的机制 还不清楚我们对吸入卤素(氯和溴)的研究表明, 神经元损伤我们以前已经确定了循环卤素加合物,形成在肺床 并导致远距离器官损伤和疾病致病性。在我们的吸入性SM损伤模型中,我们 表明循环因子如从肺组织和细胞释放的核酸可以 显著地导致肺损伤,并且清除核酸可以减轻损伤和拯救 从死亡。因此,循环因子对肺和全身损伤至关重要。越来越多的证据 表明几种这样的因子作为外泌体(一种细胞外囊泡(EV))中的货物携带。研究 已经表明EV/外来体可能是致病的。我们的初步数据显示, 从支气管肺泡灌洗液(BALF)的氯暴露大鼠是不同的外泌体货物 从对照动物的BALF中获得。此外,我们证明了从支气管肺泡灌洗液中分离的外泌体, 暴露于CEES(2-氯乙基乙基硫醚,又名:半芥子气)(SM的类似物)的动物,当加入细胞时 在培养物中呈剂量依赖性增加的炎性细胞因子和促凝血基因,重要成分 SM诱导和CEES诱导损伤的发病机制。在我们的体内研究中, 含量与BALF蛋白(肺泡屏障渗漏的标志物)相关。这些研究让我们假设 有毒化学品暴露导致致病性外泌体的释放, 炎症和凝血途径以及阻断它们的生物发生或摄取可以减轻损伤, 防止急性发病率和死亡率。因此,我们将(a)表征来源于大肠杆菌的EV/外泌体。 暴露于Cl 2和CEES的大鼠的BALF和血浆,(B)鉴定来自这些的EV/外来体通过其表达的机制。 毒性化学品暴露的动物引起损伤,和(c)评估来自毒性化学品的EV/外来体的致病性 接触化学品的动物是测试功效或生物发生或吸收抑制剂。这些研究将描述 EV/外来体影响肺损伤/疾病严重程度和消退的机制, 确定外泌体是否可以作为潜在的治疗靶点,以减轻由以下原因引起的器官损伤: 吸入有毒化学物质

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aftab Ahmad其他文献

Aftab Ahmad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aftab Ahmad', 18)}}的其他基金

Novel therapeutic targets for fluoroacetate-induced toxicities.
氟乙酸引起的毒性的新治疗靶点。
  • 批准号:
    10164787
  • 财政年份:
    2020
  • 资助金额:
    $ 44.55万
  • 项目类别:
Project 2: Attenuating Pulmonary Toxicity of Cutaneous Exposure to Arsenicals
项目 2:减轻皮肤接触砷的肺部毒性
  • 批准号:
    10249114
  • 财政年份:
    2018
  • 资助金额:
    $ 44.55万
  • 项目类别:
Extracellular RNA as therapeutic target after toxic chemical inhalation
细胞外RNA作为有毒化学物质吸入后的治疗靶点
  • 批准号:
    8985577
  • 财政年份:
    2014
  • 资助金额:
    $ 44.55万
  • 项目类别:
Extracellular RNA as therapeutic target after toxic chemical inhalation
细胞外RNA作为有毒化学物质吸入后的治疗靶点
  • 批准号:
    8934119
  • 财政年份:
    2014
  • 资助金额:
    $ 44.55万
  • 项目类别:
Hypoxic factors in pulmonary hypertension
肺动脉高压的缺氧因素
  • 批准号:
    9173032
  • 财政年份:
    2014
  • 资助金额:
    $ 44.55万
  • 项目类别:
Hypoxic factors in pulmonary hypertension
肺动脉高压的缺氧因素
  • 批准号:
    8697809
  • 财政年份:
    2014
  • 资助金额:
    $ 44.55万
  • 项目类别:
Extracellular RNA as therapeutic target after toxic chemical inhalation
细胞外RNA作为有毒化学物质吸入后的治疗靶点
  • 批准号:
    9295031
  • 财政年份:
    2014
  • 资助金额:
    $ 44.55万
  • 项目类别:
Project 2: Attenuating Pulmonary Toxicity of Cutaneous Exposure to Arsenicals
项目 2:减轻皮肤接触砷的肺部毒性
  • 批准号:
    9767160
  • 财政年份:
  • 资助金额:
    $ 44.55万
  • 项目类别:

相似海外基金

Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8429041
  • 财政年份:
    2011
  • 资助金额:
    $ 44.55万
  • 项目类别:
Analysis of extravascular lung water dynamics and exhaustive evaluation of pulmonary epithelial metabolites to establish a novel therapeutic approach for acute lung injury/ acute respiratory distress syndrome
分析血管外肺水动力学和详尽评估肺上皮代谢物,以建立急性肺损伤/急性呼吸窘迫综合征的新治疗方法
  • 批准号:
    22592023
  • 财政年份:
    2010
  • 资助金额:
    $ 44.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
OBSERVATIONAL STUDY OF ACUTE LUNG INJURY & ACUTE RESPIRATORY DISTRESS SYNDROME
急性肺损伤的观察性研究
  • 批准号:
    7603766
  • 财政年份:
    2007
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8328484
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8328493
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8602427
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8844846
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8602351
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8654999
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
  • 批准号:
    8020428
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了